Tips For Investing In Marijuana Stocks

The hype for the marijuana is not dying soon. A lot of People are seeking to invest in the marijuana industry. The companies in the marijuana industry that you can invest stocks in are the marijuana growers companies in large scale using greenhouses and other indoors growing methods, the companies that provide ancillary products and services such as the greenhouse lighting, hydroponics or packing. Another company you can invest in stocks are the biotech companies that are geared towards cannabis. The cannabis industry is growing and investing in its shares is worthwhile. The following are ways you can invest in marijuana stocks:

1. Know the Company You Want To Invest In

As you can see, there are three types of marijuana companies you can invest in. Your financial goals and personal interests in marijuana should guide you in picking the right company to invest the stocks in. Research about the company you want to invest in. There is a lot of information online. Make an informed decision before you invest.

2. Know the Possible Risks

Investing is stocks can be highly profitable. However, the chances of risks are very high too. Investing in marijuana stocks has even higher risks. The possible risks that can greatly influence the marijuana stocks negatively are the political and legal issues, imbalances in the demand and supply of marijuana and the over the counter stocks.

piggybank3. The Amount You Want To Invest

How much money are you willing to invest in marijuana? Stocks are volatile and unpredictable. So do not invest too much of your money. Invest only in what you are willing to lose. If you are not an aggressive investor, do not invest too much of money on marijuana stocks. If you want to learn how to invest in highly risky stocks such as the marijuana stocks, join the forums such as the Investors Hangout. There is so much to learn in these stock investors forums.

4. Watch Out for the Changes in the Industry

Before you invest in this industry, learn and watch out for the market trends. This is a fairly new industry and the dynamics keeps on changing every now and then. You need to consider and predict what could happen in the near future before you invest in the marijuana stocks. You need to keep watch on the industry very closely.

5. Know the Different Types of Marijuana Products

Marijuana is used for two major purposes, the Medical and Recreational marijuana. One of the major reasons for the legalization and the continued legalization of marijuana is the medical properties. There are a few countries that have legalized it for recreational use. More than 30 countries in the USA have legalized the use of marijuana for medical use. This information should guide you towards the direction you want to take in investing in the marijuana products.

The marijuana stocks are volatile and unpredictable, just like any other type of stocks. However, they show promise of a good future. The industry is a bit young and fast growing. Start investing now in this industry.

420MEDIA Trailblazers In Cannabis: Jeff Binder, CLS Holdings CEO & Chairman

mjba Business

Digital marketing agency 420MEDIA and the Marijuana Business Association (MJBA) have joined forces to create a series highlighting entrepreneurs trailblazing the cannabis scene. Each week, we profile a noteworthy business pioneer, and ask each 5 questions. This week’s featured trailblazer is Jeff Binder, CEO and Chairman of CLS Holdings USA Inc.

1. Tell us about your Company

CLS Holdings USA, Inc. is a diversified cannabis company that, subject to receipt of certain anticipated license approvals, acts as an integrated cannabis producer and retailer in Nevada and plans to expand to other states. CLS stands for “Cannabis Life Sciences,” in recognition of the company’s patented method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. Our business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

2. Why did you choose the cannabis/hemp business?

I may have to thank McDonalds for the inspiration! I have a juris doctorate degree from the National Law Center, George Washington University School of Law. I practiced law in Chicago. Five years after joining the firm, l had the good fortune of representing one of the firm’s clients, Ray Kroc, the founder of McDonald’s. Ray instilled in me good business practices and he helped me open my eyes to the world of entrepreneurship. I entered this industry very early and that is why CLS is well positioned to seek and act on opportunities of an industry in its infancy. We understand the challenge and responsibility that goes with such an undertaking with my experience.


3. What change will your firm address in the industry? Does it address an unmet need?

With new states enacting new legislation on both medicinal and recreational adult use in cannabis, our company intends on becoming an active participant in the ever-expanding marketplace by making strategic acquisitions along with continued organic growth of our existing platform in Las Vegas. We are particularly intrigued by states like Massachusetts, who are on the cusp of implementing a robust adult use marketplace. We are also actively pursuing opportunities for our patented proprietary processing technology and have started the build-out of our first facility at our Nevada location and are entering dialogue and discussion with many of the prominent players in Canada.

4. What has been the market reaction?

We understand that this is a marketplace that requires knowledge and the ability to rapidly access the capital markets to be in a position to win and/or execute on some of these unique opportunities. It’s our view at CLS that we are in the very beginning stages of a rapidly developing legal cannabis marketplace with new rules and regulations, which are becoming more favorable. CLS should be able to rapidly grow its existing business along with making substantial accretive acquisitions. It is our goal in the coming years to create and maximize shareholder value by generating revenues with fundamental support.


5. Are there any upcoming milestones for your company?

We just announced that CLS has executed two Letters of Intent (LOIs) to enter the rapidly growing Massachusetts market, which has been operating as a legalized medical jurisdiction since 2015 and has approved legalized recreational use. We agreed to loan $5 million to In Good Health, a licensed medical dispensary in Brockton, Massachusetts. Along with the loan, CLS will have an option to acquire it. The Brockton dispensary was the second licensed dispensary in the state and has been operational since September 2015 and is currently servicing 17,000 registered patients and delivering to 1,700 homes with key product offerings of flower, concentrates, vapes, edibles, pre-rolls and tinctures.

We continue to be enthusiastic about Oasis Cannabis in Las Vegas. The opportunity that we saw two years ago is developing along the lines that we anticipated. We have a strong team in place that has substantial knowledge of the cannabis marketplace in Las Vegas and the US. We are also incredibly excited about the prospects of our City Trees Brand. We currently have distribution in 25+ dispensaries in the Las Vegas marketplace are working on making it one of Las Vegas most recognizable cannabis brands.

Where can readers learn more?

Readers can visit our page for our dispensary by visiting

For additional information on CLS, please visit:

Vape Co. CEO: Trump’s Trade War Will Stifle The Cannabis Industry

The 25% increase in tariffs impact on vaping & cannabis

NEW YORK:  Today, The Blinc Group’s Co-CEO,  Arnaud Dumas de Rauly,  is testifying at The Office of the U.S. Trade Representative (USTR) public hearings regarding proposed tariffs on approximately $16 billion worth of Chinese products.

These proposed tariffs increases – including HTS No. 8543709930 and HTS No. 8543709940 related to vapor product devices, batteries intended for use in vaping devices, and pre filled pods and cartridges – will do great harm to American businesses, medical marijuana patients and adult use consumers while doing nothing to empower American companies to manufacture these products themselves.

The current administration’s trade war raged against China will:

  1. Reduce access to reduced risk vapor products and therapeutic cannabis products to American citizens,

  2. Not bring back jobs to America,

  3. Cut current medical marijuana and adult use States tax revenues by over 25%,

“Increasing tariffs may have worked 20 years ago, when US manufacturing was at its highest, but given the current economy, it is a major mistake to believe that this will bring jobs back to American citizens,” said Dumas de Rauly. 

With regards to taxes, “The State of Colorado has collected over $247M in Cannabis tax revenue in 2017. Considering that over the same period, cannabis vaping products comprised 25% of sales volumes, the loss of taxes due to non-availability of the products, would represent $61.75M, which represents the cost of educating 10,445 students. Yes ladies and gentlemen, this revenue is used to fund education, regulation, substance abuse prevention and treatment programs.”

For access to the full pre-hearing testimony of The Blinc Group, please click here.

MedMen Announces Acquisition Of Florida Marijuana License And Cultivation Facility

CALIFORNIA: MedMen, the country’s leading cultivator, producer and retailer of state-sanctioned cannabis, has signed a definitive agreement to acquire dispensary and cultivation assets from Florida-based Treadwell Nursery.

As part of the transaction, MedMen will acquire Treadwell Nursery’s cultivation facility situated on 5 acres in Eustis, Florida and the right to open 25 medical marijuana dispensaries in the State of Florida.

Screenshot 2018-06-07 09.02.52“For nearly a decade we have been positioning ourselves to capitalize on enormous market opportunities like this,” said MedMen Co-founder and CEO Adam Bierman. “This acquisition is right in line with our strategy of establishing a presence early on in high potential markets with limited licenses and large populations. Florida is the third most populous state in the country with a medical marijuana market estimated to reach $1 billion in annual sales by 2020. MedMen has built the best-in-class brand, and we continue to invest in premium assets that solidify our dominant position in the most important cannabis markets in the world.”

MedMen employs more than 800 people and currently operates 18 licensed cannabis facilities in cultivation, manufacturing and retail in California, Nevada and New York. The addition of Florida expands the Company’s reach to yet another key market in the fastest growing industry in the country.

As consideration for the acquisition, the Company will pay US$53 million, subject to a working capital adjustment, half of which will be satisfied in cash and the other half of which will be satisfied by way of issuance of common units of MM Enterprises, a subsidiary of the Company, which by their terms are redeemable for Class B Subordinate Voting Shares of the Company. In respect of the cash consideration, the LLC will pay Treadwell Nursery US$6,625,000 on the closing date and on each of the dates that are three (3), six (6) and nine (9) months after the closing date. In respect of the Redeemable Units, the number of units will be based on the lesser of the closing trading price of the Subordinate Voting Shares on the Canadian Securities Exchange as of June 4, 2018 or the two-week weighted average daily closing price prior to the closing of the transaction.

The transaction is expected to close within 90 days and is subject to customary closing conditions, including receipt of state regulatory approvals. If certain regulatory approvals are not obtained, the Company and Treadwell Nursery will have the right to terminate the Agreement.

Medbox Featured on WSJ's MarketWatch

CALIFORNIA: Medbox, Inc. (OTC Markets: MDBX) (, a leader in providing consulting services and patented inventory control, compliance, and dispensing systems to the medical and retail industries, announced that they have been featured in The Wall Street Journal MarketWatch. [Read more…]